Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 USD | -7.96% | -11.71% | +22.80% |
Mar. 12 | Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating | MT |
Mar. 12 | Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating | MT |
Business Summary
Number of employees: 209
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Telehealth
64.3
%
| 83 | 69.4 % | 98 | 64.3 % | +18.76% |
WorkSimpli
35.7
%
| 36 | 30.6 % | 54 | 35.7 % | +49.50% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 119 | 100.0 % | 153 | 100.0 % | +28.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Justin Schreiber
CEO | Chief Executive Officer | 40 | - |
Marc Benathen
DFI | Director of Finance/CFO | 43 | 21-02-28 |
Dennis Wijnker
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-12 |
Chief Tech/Sci/R&D Officer | 52 | 21-01-10 | |
Joseph DiTrolio
BRD | Director/Board Member | 73 | 13-05-28 |
Sales & Marketing | 39 | 23-01-03 | |
James Porte
PRN | Corporate Officer/Principal | - | - |
Eric Yecies
LAW | General Counsel | 46 | 20-11-19 |
Nicholas Alvarez
PRN | Corporate Officer/Principal | 32 | 17-12-31 |
Maria Stan
AUD | Comptroller/Controller/Auditor | 48 | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Will Febbo
BRD | Director/Board Member | 55 | 23-06-19 |
Naveen Bhatia
BRD | Director/Board Member | 43 | 21-09-07 |
John Strawn
BRD | Director/Board Member | 62 | 11-06-30 |
Roberto Simon
BRD | Director/Board Member | 48 | 20-11-05 |
Joseph DiTrolio
BRD | Director/Board Member | 73 | 13-05-28 |
Stefan Galluppi
PRN | Corporate Officer/Principal | 37 | 17-02-22 |
Justin Schreiber
CEO | Chief Executive Officer | 40 | - |
Robert Jindal
BRD | Director/Board Member | 52 | 22-09-13 |
Joan LaRovere
BRD | Director/Board Member | - | 23-02-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,469,087 | 30,261,358 ( 74.78 %) | 103,040 ( 0.2546 %) | 74.78 % |
Stock B | 0 | 1,400,000 | 0 | 0 |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.80% | 411M | |
+21.23% | 37.65B | |
+8.26% | 6.99B | |
+14.92% | 3.74B | |
-0.91% | 3.73B | |
-27.35% | 1.27B | |
-22.30% | 1.34B | |
-32.52% | 944M | |
-25.64% | 846M | |
-7.60% | 826M |
- Stock
- Equities
- Stock LifeMD, Inc. - Nasdaq
- Company LifeMD, Inc.